跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
OYONE 40/20 oxycodone hydrochloride 40 mg / naloxone hydrochloride 20 mg modified release tablet blister pack
Approved
STANDARD
OYONE 40/20 oxycodone hydrochloride 40 mg / naloxone hydrochloride 20 mg modified release tablet blister pack
Maple Healthcare Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Oct 21, 2025
Approval ID
0ae3750baf942534
Company
Maple Healthcare Pty Ltd
Type
Standard
Approval Details
Approval Id
0ae3750baf942534
Product Name
OYONE 40/20 oxycodone hydrochloride 40 mg / naloxone hydrochloride 20 mg modified release tablet blister pack
Artg Id
462787
Artg Name
OYONE 40/20 oxycodone hydrochloride 40 mg / naloxone hydrochloride 20 mg modified release tablet blister pack
Sponsor
Maple Healthcare Pty Ltd
Company Detail Path
/organization/maple-healthcare-pty-ltd
Artg Date
2025-10-20
Registration Type
Medicine
Therapeutic Good Type
Medicines
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Oct 21, 2025
Approval ID
0ae3750baf942534
Type
Standard
Back to TGA Approvals
OYONE 40/20 oxycodone hydrochloride 40 mg / naloxone hydrochloride 20 mg modified release tablet blister pack - TGA Drug Approval Details